Earnings Scheduled For November 12, 2021
Companies Reporting Before The Bell
• Zevia (NYSE:ZVIA) is estimated to report quarterly loss at $0.43 per share on revenue of $34.40 million.
CASI Pharmaceuticals Earnings Preview
CASI Pharmaceuticals (NASDAQ:CASI) is set to give its latest quarterly earnings report on Friday, 2021-11-12. Here's what investors need to know before the announcement.
Analysts estimate that CASI Pharmaceuticals will likely report an Earnings Per Share (EPS) of $-0.05
CASI Pharma Reports Its Partner, BioInvent, To Present Further Clinical Data On BI-1206 At American Society Of Hematology
~ BI-1206 restores rituximab activity in relapsed or refractory patients
~~ Demonstrates ORR 50%, DCR 58%, with complete responses lasting beyond 18 and 24 months
ROCKVILLE, Md., and BEIJING, Nov. 5, 2021 /PRNewswire/
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Oct. 6)
60 Biggest Movers From Yesterday
Gainers
Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value of $2.26 billion.
35 Stocks Moving In Monday’s Mid-Day Session
Gainers
Trillium Therapeutics Inc. (NASDAQ: TRIL) shares climbed 187.8% to $17.53 after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value of $2.26 billion.
4 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
